In our small, pilot trial, administration of cyclosporine at the time of reperfusion was associated with a smaller infarct by some measures than that seen with placebo. These data are preliminary and require confirmation in a larger clinical trial.
No takes yet. Share an insight, caveat, or question.
Piot et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: